Postes actifs de Ronald Bronsaer
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
CellMade SAS
 CellMade SAS Medical SpecialtiesHealth Technology CellMade SAS develops inflammatory biomarkers for drug discovery and clinical diagnostics. The firm's services include inflammation bio bank, inflammation discovery, anti-inflammatory toxicity and companion diagnostics. Its products and services are used in a range of applications from research and development to drug screening. The company was founded by Ronald Bronsaer in 2007 and is headquartered in Marseille, France. | Directeur Général | 24/06/2009 | - |
| Président | 24/06/2009 | - | |
| Fondateur | 01/01/2007 | - |
Historique de carrière de Ronald Bronsaer
Anciens postes connus de Ronald Bronsaer
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| CAMBREX CORPORATION | Corporate Officer/Principal | 01/01/2007 | 01/01/2007 |
Statistiques
Internationale
| France | 2 |
| Etats-Unis | 2 |
Opérationnelle
| Chief Executive Officer | 1 |
| Chairman | 1 |
| Founder | 1 |
Sectorielle
| Health Technology | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 2 |
|---|---|
CellMade SAS
CellMade SAS Medical SpecialtiesHealth Technology CellMade SAS develops inflammatory biomarkers for drug discovery and clinical diagnostics. The firm's services include inflammation bio bank, inflammation discovery, anti-inflammatory toxicity and companion diagnostics. Its products and services are used in a range of applications from research and development to drug screening. The company was founded by Ronald Bronsaer in 2007 and is headquartered in Marseille, France. | Health Technology |
Cambrex Corp.
 Cambrex Corp. Pharmaceuticals: GenericHealth Technology Cambrex Corp. engages in the provision of products, services, and technologies to accelerate and improve the development and commercialization of new and generic therapeutics. It supplies to innovator and generic pharmaceutical companies. Its products include generic and branded APIs, controlled substances, chiral compounds, high potency APIs, and advanced intermediates. The company was founded by Arthur Mendolia and Cyril C. Baldwin Jr. in 1981 and is headquartered in East Rutherford, NJ. | Health Technology |
- Bourse
- Insiders
- Ronald Bronsaer
- Expérience
